Coenzyme A (CoA) mediates thiol-based acyl-group transfer (acetylation and palmitoylation). However, a role for CoA in the thiol-based transfer of NO groups (S-nitrosylation) has not been considered. Here we describe protein S-nitrosylation in yeast (heretofore unknown) that is mediated by S-nitroso-CoA (SNO-CoA). We identify a specific SNO-CoA reductase encoded by the alcohol dehydrogenase 6 (ADH6) gene and show that deletion of ADH6 increases cellular S-nitrosylation and alters CoA metabolism. Further, we report that Adh6, acting as a selective SNO-CoA reductase, protects acetoacetyl-CoA thiolase from inhibitory S-nitrosylation and thereby affects sterol biosynthesis. Thus, Adh6-regulated, SNO-CoA-mediated protein S-nitrosylation provides a regulatory mechanism paralleling protein acetylation. We also find that SNO-CoA reductases are present from bacteria to mammals, and we identify aldo-keto reductase 1A1 as the mammalian functional analog of Adh6. Our studies reveal a novel functional class of enzymes that regulate protein S-nitrosylation from yeast to mammals and suggest that SNO-CoA-mediated S-nitrosylation may subserve metabolic regulation.
Coenzyme A (CoA) mediates thiol-based acyl-group transfer (acetylation and palmitoylation). However, a role for CoA in the thiol-based transfer of NO groups (S-nitrosylation) has not been considered. Here we describe protein S-nitrosylation in yeast (heretofore unknown) that is mediated by S-nitroso-CoA (SNO-CoA). We identify a specific SNO-CoA reductase encoded by the alcohol dehydrogenase 6 (ADH6) gene and show that deletion of ADH6 increases cellular S-nitrosylation and alters CoA metabolism. Further, we report that Adh6, acting as a selective SNO-CoA reductase, protects acetoacetyl-CoA thiolase from inhibitory S-nitrosylation and thereby affects sterol biosynthesis. Thus, Adh6-regulated, SNO-CoA-mediated protein S-nitrosylation provides a regulatory mechanism paralleling protein acetylation. We also find that SNO-CoA reductases are present from bacteria to mammals, and we identify aldo-keto reductase 1A1 as the mammalian functional analog of Adh6. Our studies reveal a novel functional class of enzymes that regulate protein S-nitrosylation from yeast to mammals and suggest that SNO-CoA-mediated S-nitrosylation may subserve metabolic regulation.
denitrosylase | S-nitrosylation | Adh6 | AKR1A1 | denitrosylation S -nitrosylation, a phylogenetically conserved posttranslational modification of proteins that mediates transduction across a broad spectrum of cellular signaling pathways, involves the covalent addition of NO groups to Cys thiols to generate S-nitrosothiols (SNOs) (1) . There is increasing evidence that S-nitrosylation is regulated enzymatically (2, 3) . One highly conserved enzyme implicated in regulating S-nitrosylation is represented by S-nitroso-glutathione (GSNO) reductase (GSNOR), which metabolizes the low-molecular-weight SNO, GSNO, by using reducing equivalents from NADH (4) . Because many S-nitrosylated proteins (SNO-proteins) are in equilibrium with GSNO, GSNOR plays a major role in regulating protein S-nitrosylation/denitrosylation (4) (5) (6) .
Coenzyme A (CoA) is an abundant, low-molecular-weight thiol that plays an essential role in cells through involvement in >100 reactions of intermediary metabolism (7, 8) . Although CoA can be S-nitrosylated in vitro (9) , endogenous S-nitrosylation of CoA has not been reported, and a role for S-nitroso-CoA (SNO-CoA) in protein S-nitrosylation has not been considered. We wondered whether an enzymatic activity might be involved in regulating the abundance of SNO-CoA and thereby protein S-nitrosylation/ denitrosylation (analogous to regulation by GSNOR). We focused initially on an experimentally tractable model eukaryote, the yeast Saccharomyces cerevisiae.
Results
Adh6 Is a SNO-CoA Reductase in Yeast. In extracts of yeast, NADPH, but not NADH, oxidation was greatly enhanced in the presence of SNO-CoA ( Fig. 1 A and B) , consistent with the operation of an NADPH-specific SNO-CoA reductase. Addition of SNOCoA to yeast lysates led to the S-nitrosylation of multiple proteins as demonstrated by the SNO-Resin Assisted Capture (SNO-RAC) method (10) , and coaddition of NADPH (but not NADH) markedly diminished SNO-protein formation (Fig. 1C) . Thus, in yeast, SNO-CoA can serve as a source of NO groups for protein S-nitrosylation that may be regulated by NADPHdependent SNO-CoA reductase activity. SNO-CoA-metabolizing activity was purified from yeast to homogeneity, as assessed by SNO-CoA-dependent NADPH consumption, and identified as the NADPH-dependent enzyme alcohol dehydrogenase 6 (Adh6; product of the ADH6 gene) (Fig. 1D, Fig. S1 A and B, and Table  S1 ), a member of the cinnamyl alcohol dehydrogenase family (11, 12) with no previously known physiological roles or substrates. NADPH-dependent catabolism of SNO-CoA by Adh6 was confirmed directly with isolated, recombinant Adh6 (Fig.  S3A ). CoA-sulfinamide was identified by mass spectrometry (MS) as the major stable product of SNO-CoA metabolism ( Fig.  2A and Fig. S2 A and B) , confirming a reductase mechanism that produces an S-(N-hydroxy)-CoA intermediate (Fig. S2D ). Kinetic analysis with SNO-CoA as substrate gave a K m of 180.5 ± 16.8 μM, an estimated k cat of 2,596.5 ± 110.7 min −1 ( Fig. 2B and Fig. S3B ), and a stoichiometry with cosubstrate NADPH of 1:1 (Fig. 2C) . The catalytic efficiency (k cat /K m ) of Adh6 (for substrate SNOCoA) compares closely with that of microbial GSNOR (for substrate GSNO) (4), supporting physiological relevance (and as for GSNOR, a relatively high K m is consistent with a homeostatic functional role). Importantly, Adh6 was specific for SNO-CoA vs. GSNO or S-nitroso-cysteine (CysNO), oxidized CoA or CoAglutathione mixed disulfide ( Fig. 2D and Fig. S4 A and B) . Adh6 is Significance Coenzyme A (CoA) is a small-molecular-weight thiol that plays a central role in cellular metabolism. We have discovered a novel, phylogenetically conserved class of enzymes that reduce S-nitroso-CoA (SNO-CoA) and thereby regulate protein S-nitrosylation. These denitrosylases, identified as alcohol dehydrogenase 6 (Adh6) in yeast and aldo-keto reductase 1A1 in mammals, may be analogized to deacetylases, which regulate CoA-mediated protein acetylation. In yeast, Adh6 (previously without ascribed cellular function) regulates endogenous protein S-nitrosylation (heretofore unknown) including functionaltering S-nitrosylation that impacts CoA-related metabolism. Thus, our findings establish a novel role for CoA in protein S-nitrosylation (operating through SNO-CoA), which is governed by specific enzymes. This mechanism may regulate the influence of nitric oxide on cellular metabolism in health and disease. the principal source of SNO-CoA-metabolizing activity, because genetic deletion of ADH6 (adh6Δ) resulted in ∼80% decrease in SNO-CoA-consuming activity in lysates, whereas deletion of closely homologous ADH7 (Fig. S5A ) had no effect (Fig. 2E) .
SNO-CoA-Mediated Protein S-Nitrosylation Is Regulated by Adh6. In yeast, GSNOR-regulated denitrosylation of SNO-proteins (coupled to metabolism of GSNO) protects against nitrosative stress imposed by exogenous NO, as demonstrated by enhanced susceptibility to nitrosative challenge in GSNOR-null cells (4, 13) . In contrast, deletion of ADH6 did not affect the growth response to nitrosative stress (Fig. S5B) , suggesting distinct functions for SNO-CoA and GSNO. To reveal possible roles for SNO-CoA-and in particular to explore a possible role for SNO-CoA in metabolic signalingwe used a MS-based approach to identify substrates of SNOCoA-mediated, Adh6-regulated protein S-nitrosylation. We treated lysates of wild-type (WT) yeast with SNO-CoA (which is not cell-permeable) and treated intact WT and adh6Δ yeast with the cell-permeable S-nitrosylating agent, S-nitroso-cysteine ethyl ester (EtCysNO). NO groups originating from EtCysNO will distribute among intracellular SNOs (14) , forming SNO-CoA (Fig. S6) , and as shown in Fig. 3A and detailed below, there is substantial overlap between the sets of proteins S-nitrosylated by EtCysNO or SNO-CoA. SNO-proteins were captured by SNO-RAC (10), and tryptic peptides were quantified by isobaric tags for relative and absolute quantification (iTRAQ) and liquid chromatography-coupled tandem MS (LC-MS/MS) (detailed in SI Materials and Methods).
Treatment of lysates with SNO-CoA (60 μM, 10 min) resulted in the identification of 345 SNO-proteins ( Fig. 3A and Dataset S1). SNO-CoA-induced protein S-nitrosylation was greatly attenuated in WT lysates by the addition of NADPH, and this attenuation was partially eliminated in adh6Δ lysates (Fig. 3B) , confirming regulation by Adh6 of SNO-CoA-mediated protein S-nitrosylation. Similarly, treatment of intact cells with EtCysNO (100 μM, 2 h) resulted in the identification of 103 SNO-proteins ( Fig. 3C and Dataset S2), and iTRAQ analysis revealed that ADH6 deletion resulted in significantly enhanced S-nitrosylation of 15 of those proteins (Fig. 3C, Upper) . Notably, 10 of 15 proteins exhibiting Adh6-dependent enhanced S-nitrosylation after EtCysNO treatment of intact cells were identified as SNO-CoA substrates in lysates ( Fig. 3C , Upper; Datasets S1 and S2). The majority of substrates for Adh6-regulated S-nitrosylation were identified as metabolic enzymes (Fig. 3C) , including Erg10 (acetoacetyl-CoA thiolase) ( Fig. 3C and Fig. S7A ), which plays a key role in CoA-dependent sterol biosynthesis (15) , as well as several enzymes influencing acylCoA levels (see below). We further confirmed that the enhanced S-nitrosylation of Erg10 in adh6Δ yeast did not reflect changes in Erg10 abundance ( Representative Coomassie-stained SDS/PAGE gel corresponding to the five-step chromatographic purification scheme detailed in Table S1 , which yielded from a crude extract (lane 1) 2,826-fold enrichment of NADPH-dependent SNO-CoA reductase activity identified by MS as Adh6 (lane 6). (Table S1 and Fig. 1D ) (20 nM) was incubated with NADPH (100 μM) and SNO-CoA, GSNO, or CysNO (100 μM), and NADPH consumption was measured over time. (E) Adh6 is the principal source of NADPH-dependent SNO-CoA reductase activity. Activity was assayed in lysates from WT yeast and adh6Δ, adh7Δ, and adh6Δadh7Δ yeast. Data are presented as mean ± SD; n = 3.
Endogenous S-Nitrosylation and Regulation by Adh6 of Erg10 Activity.
In yeast, as in bacteria, NO is generated by respiratory enzymes that reduce nitrite and/or nitrate [i.e., NO is produced in the absence of a nitric oxide synthase (NOS) (1, 16) ]. However, endogenous protein S-nitrosylation has not been described in yeast, and in general the role of yeast NO is unknown. Our analysis revealed constitutive protein S-nitrosylation in yeast under basal conditions with both SNO-RAC (Fig. 3 C, lower list, and D) and mercury-coupled photolysis/chemiluminescence (Fig. 3E ) and identified 51 endogenous SNO proteins (Dataset S2). Notably, 37 of 51 endogenous substrates were also identified as targets of exogenous SNO-CoA (Datasets S1 and S2). In addition, five endogenous SNO-proteins exhibited enhanced basal S-nitrosylation in the absence of Adh6 (Fig. 3C , lower list, and Dataset S2), and three of these substrates were among the set identified as targets of exogenous SNO-CoA, including Erg10 thiolase (Fig. S7C ). Acetoacetyl-CoA thiolase has also been identified by proteomic analysis as an endogenous SNOprotein in mammals (17, 18) . Both endogenous and exogenous SNO-CoA-mediated S-nitrosylation of Erg10 were confirmed directly by SNO-RAC analysis of untreated extracts and extracts treated with SNO-CoA (60 μM, 10 min) ( Fig. 3F and Fig. S7 A and C). Nitrite-dependent NO production by yeast mitochondria is enhanced under hypoxic conditions (16) . Supplementation of intact yeast with nitrite (100 μM) under hypoxia to enhance endogenous NO production led to the progressive accumulation of SNO-proteins as assessed by photolysis/chemiluminescence (Fig. 4A ), and these increases in endogenous SNO-protein levels were substantially greater in adh6Δ vs. WT yeast (Fig. 4B) . Thus, collectively, these data support a role for SNO-CoA in endogenous protein S-nitrosylation in yeast that is regulated by Adh6 and indicate that SNO-CoA-mediated, Adh6-regulated protein S-nitrosylation is coupled to endogenous NO production.
To illustrate regulation of metabolism through endogenous SNO-CoA-mediated protein S-nitrosylation, we focused on Erg10 (identified as a substrate for Adh6-regulated S-nitrosylation by both endogenous and exogenous SNO-CoA; Fig. 3C and F and Fig. S7 A and C). Nitrite supplementation of hypoxic yeast cultures to enhance endogenous S-nitrosylation resulted in inhibition of acetoacetyl-CoA thiolase activity (Fig. 4C) , and this inhibition was significantly greater in adh6Δ vs. WT cells (Fig. 4C) , implicating SNO-CoA. Treatment of normoxic cultures with EtCysNO (100 μM) revealed similar regulation of thiolase activity by Adh6 (Fig. 4C) , specifically implicating SNO-CoA in the inhibitory effects of EtCysNO (recall that Adh6 does not metabolize CysNO; Fig. 2D ). Moreover, we verified in yeast extracts and with purified protein (IC 50 = 4 μM) that SNO-CoA potently inhibited Erg10 thiolase activity (Fig. 4 D  and E) , whereas, notably, neither GSNO (Fig. 4D ) nor succinylCoA (a CoA analog) (Fig. 4E) had a significant effect. That is, thiolase is selectively inhibited by SNO-CoA, and, thus, the inhibition of thiolase that is coupled to endogenous NO production or exogenous nitrosative stress (and regulated by the SNO-CoA reductase Adh6) is likely to be selectively mediated by SNO-CoA. Erg10 is a critical component of the CoA-based mevalonate pathway for sterol biosynthesis; yeast lacking Erg10 are mevalonate auxotrophs (15) . To establish a functional corollary of thiolase inhibition by SNO-CoA, we carried out metabolomic analyses in WT vs. adh6Δ yeast, focusing on components of CoA-based metabolism, including mevalonate. Metabolomic analysis demonstrated that treatment with EtCysNO, under conditions used to demonstrate SNO-CoA-mediated Erg10 S-nitrosylation (Fig. 3 A and C) , resulted in a significant decrease of mevalonate levels in adh6Δ yeast, but not in WT yeast (Fig. 4F) , consistent with inhibition of Erg10 activity by SNO-CoA (Fig. 4I) . As a measure of the effect of Erg10 inhibition by SNO-CoA on mevalonate biosynthesis, mevalonate levels in EtCysNO-treated adh6Δ yeast were similar to the levels observed in yeast harboring the erg10-DAmp gene (Fig. 4F) , which codes for a form of Erg10 that exhibits ∼50% reduction in thiolase activity (Fig. S7D) . In addition, metabolomic analysis revealed that treatment with EtCysNO resulted in large decreases in free CoA (Fig. 4G) , consistent with formation of SNO-CoA (Fig. S6 A-G) (which escapes detection at physiological concentrations, as is the case for other unstable, short-lived SNOs, including GSNO and CysNO; note that SNO-CoA is not regenerated to CoA by Adh6). However, whereas levels of precursor CoA and downstream product mevalonate were decreased, levels of acetyl-CoA were increased, and this increase was significantly larger in adh6Δ vs. WT cells (Fig. 4H) . Metabolic blockade of acetyl-CoA utilization although Erg10, which would also contribute to decreased levels of CoA, may play a role in enhancement of acetyl-CoA levels (Fig. 4I) . However, it is well known that acetyl-CoA generation is governed in large part by fatty acid (β-)oxidation, which is enhanced by S-nitrosylation (19) , and by the pyruvate dehydrogenase multienzyme complex, and we identified some components of those mechanisms as SNO-proteins (Datasets S1 and S2), including components of the pyruvate dehydrogenase complex that exhibited Adh6-regulated S-nitrosylation ( Fig. 3C and Dataset S2). Thus, Adh6-regulated S-nitrosylation may potentially signal through modification of multiple components of CoA-related metabolic pathways. Finally, it is important to note that constitutive levels of acetyl-CoA were increased significantly in adh6Δ vs. WT yeast in the absence of exogenous SNO (Fig. 4H) , indicating directly metabolic regulation by endogenous SNO-CoA. Adh6 is thus a newly discovered SNO-CoA reductase that influences CoA metabolism in yeast.
AKR1A1 Is a SNO-CoA Reductase in Mammals. Adh6 is unique to yeast (phylum Ascomycetes). However, the generality of our findings is indicated by our discovery of NADPH-dependent SNO-CoA reductase activity across a phylogenetic spectrum from bacteria to mammals (Fig. 5 A and B; see also Fig. 6D ). As in yeast, addition of SNO-CoA to lysates of mouse tissues led to the S-nitrosylation of multiple proteins, and coaddition of NADPH (but not NADH) markedly diminished SNO-protein formation (Fig. 5C) . Using an approach identical in all significant respects to that used in the analysis of Adh6 in yeast, we purified (from bovine liver and kidney) the mammalian SNO-CoA reductase and identified it as aldo-keto reductase 1A1 (AKR1A1) (Fig. 5D and Figs. S2C and S8 A and B) . (F-H) Effects of enhanced S-nitrosylation on the metabolic profile of the mevalonate pathway. Midlog phase yeast were untreated or treated with 100 μM (F) or 500 μM (G and H) EtCysNO for 2, and metabolites (mevalonate, CoA, and acetyl-CoA) were measured as described in SI Materials and Methods. Data are mean ± SD (n = 5 or 6). *P < 0.05 (by Student t test in F and G and by ANOVA in H, normalized with respect to culture turbidity). Note in F that erg10-DAmP yeast exhibits ∼50% of WT thiolase activity (Fig. S7D) . (I) Schematic summary of the potential role of SNO-CoA-mediated protein S-nitrosylation in regulation of Erg10-dependent metabolism. Erg10 converts acetylCoA to free CoA and acetoacetyl-CoA, a precursor via 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) in mevalonate biosynthesis. S-nitrosylation of Erg10 by SNO-CoA, regulated by Adh6 acting as a SNO-CoA reductase, inhibits thiolase activity, resulting in decreased levels of mevalonate and may contribute to diminished levels of CoA and increased levels of acetyl-CoA. Altered levels of CoA and acetyl-CoA may reflect actions of Adh6-regulated SNO-CoA at additional loci (FAox, fatty acid β-oxidation; PDC, pyruvate dehydrogenase multienzyme complex). SNO-CoA reductase thus acts as a cognate denitrosylase for substrates of SNO-CoA by direct analogy to GSNOR, which acts as a denitrosylase for protein substrates of GSNO.
the physiological role of AKR1A1 remains unknown, with the exception of a role in vitamin C synthesis that has been demonstrated in the mouse (21), although many mammals, including humans, do not synthesize vitamin C. MS analysis demonstrated that the reductive mechanism (involving hydride transfer; Fig. 6A and Fig.  S2D ) and product (CoA-sulfinamide; Fig. S2C ) of AKR1A1 operating as a SNO-CoA reductase were identical to those of yeast Adh6. Kinetic analysis, with SNO-CoA as substrate, gave a K m of 20.5 ± 1.8 μM and an estimated k cat of 627 ± 23.76 min −1 (Fig. 6B and Fig. S3 C and D) , and, as for Adh6, a stoichiometry with cosubstrate NADPH of 1:1 (Fig. 6C ). AKR1A1 and Adh6 are evolutionarily unrelated and are therefore functional analogs. The existence of evolutionarily unrelated functional analogs in yeast and mammals indicates strongly that SNO-CoA reductase activity is biologically significant.
Transgenic mice bearing an unconditional knockout of AKR1A1 were generated (Fig. S8 C and D) to demonstrate that AKR1A1 is the predominant source of NADPH-dependent SNO-CoA reductase activity in mammalian tissue (Fig. 6D and Fig. S8E ), and these results were confirmed by immunodepletion of AKR1A1 from tissue extracts (Fig. S8F ). To illustrate regulation by AKR1A1 of endogenous SNO-CoA-mediated protein S-nitrosylation, we focused as an exemplar on glyceraldehyde 3-phosphate dehydrogenase (GAPDH). GAPDH is best characterized among the multitude of mammalian metabolic enzymes that are regulated by S-nitrosylation, which includes both loss-and gain-of-function roles for SNO-GAPDH in metabolic regulation (22) , metabolic inflammation (23) , and glycolysis (24) . Further, GAPDH is among the set of SNO-proteins in which S-nitrosylation is not regulated through coupling to GSH/GSNO (i.e., is independent of GSNOR) (25) and that we find is mediated effectively by SNO-CoA (Dataset S1). Analysis by SNO-RAC in AKR1A1-null and WT tissues, followed by either Western blotting (Fig. 6E ) or iTRAQ-MS (Fig. 6F) , showed that SNO-GAPDH levels are enhanced substantially in the absence of AKR1A1. Thus, SNO-CoA is likely a principal lowmolecular-weight SNO that exists in equilibrium with SNO-GAPDH to regulate GAPDH S-nitrosylation/denitrosylation, with AKR1A1 serving to control that equilibrium.
Discussion
Our results reveal a new functional class of enzymes, SNO-CoA reductases, and establish a phylogenetically conserved role for this enzymatic machinery in the regulation of protein S-nitrosylation. Our findings include, to our knowledge, the first demonstration of endogenous S-nitrosylation in yeast and the identification of SNOCoA as a novel signaling molecule. Endogenous SNOs in a variety of low-molecular-weight and protein forms may purvey NO bioactivity. However, assignments of individual roles for ephemeral small-molecular-weight SNOs in cellular function can only be achieved through the identification of dedicated enzymes that metabolize individual SNOs (it is important to appreciate in this regard that no enzymes have been found to metabolize NO in mammals that would allow assignment of function to NO that is independent of SNOs). Here, as in previous analyses of the role of GSNO in protein S-nitrosylation based on genetic manipulation of the GSNO-metabolizing enzyme GSNOR (4, 5), we used genetic manipulation of novel, specific SNO-CoA-metabolizing enzymes to establish a role for SNO-CoA in NO-based cellular signaling.
Our findings demonstrate that, in cells producing or otherwise exposed to NO, SNO-CoA may serve as a source of NO groups for protein S-nitrosylation and that protein S-nitrosylation regulated by SNO-CoA reductases may provide a mechanism for metabolic regulation by NO. In particular, in yeast, regulation by the dedicated SNO-CoA reductase, Adh6, of Erg10 S-nitrosylation demonstrates a previously unsuspected locus of control of sterol metabolism. Adh6 may thereby protect yeast against sterol auxotrophy caused by endogenous or exogenous (e.g., host-derived or soil) NO. More generally, the disruption of CoA homeostasis (e.g., CoA depletion) that we observed upon treatment of yeast with an S-nitrosylating agent may exemplify nitrosative stress experienced by microbes upon infection of mammalian cells, and a protective role for Adh6 may likely entail an effective mechanism to regenerate CoA from CoA-sulfinamide (Fig. 2A) . The regulation in mammals by a cognate SNO-CoA reductase of GAPDH S-nitrosylation, extensively characterized as an exemplar of metabolic signaling by NO (22) (23) (24) , supports the prediction that SNO-CoA may convey metabolic signals more broadly. Further, S-nitrosylated GAPDH has been shown recently to function as an S-nitrosylase and thereby to serve as an important regulator of protein acetylation within the nucleus that impacts cellular metabolism (22) . Thus, our findings suggest that S-nitrosylation and acetylation provide distinct CoA-based mechanisms for posttranslational protein modification that will together exert a broad functional purview in most or all cells, with implications for both physiology and disease.
Materials and Methods
Purification of Yeast and Mammalian SNO-CoA Reductases. SNO-CoA-metabolizing activity was purified from a crude extract of yeast cells and bovine kidneys by ammonium sulfate precipitation followed by several steps of column chromatography (SI Materials and Methods). The specific activity of NADPH-dependent SNO-CoA reduction was used to assess purification at each step.
Kinetic Parameters of Adh6 and AKR1A1. Kinetic analysis was carried out with purified Adh6 and AKR1A1. The reactions contained a fixed concentration of NADPH (100 μM) and several concentrations of SNO-CoA. Further details are provided in SI Materials and Methods.
Metabolomic Analysis. In extracts of WT and adh6Δ yeast (untreated and following treatment with EtCysNO), mevalonate, CoA, and acetyl-CoA were separated and quantified by GC-MS (mevalonate) or LC-MS/MS (CoA and acetyl-CoA), as described in SI Materials and Methods.
SNO-RAC Assay and iTRAQ Labeling for Quantification of Protein S-Nitrosylation.
Protein S-nitrosylation was assessed by the SNO-RAC assay (10) , and differences in the profile of protein S-nitrosylation in WT vs. adh6Δ yeast (under basal growth conditions and upon treatment of cells with EtCysNO) were quantified by iTRAQ labeling (SI Materials and Methods).
Animals. Mouse studies were approved by the Case Western Reserve University Institutional Care and Use Committee (IACUC); housing and procedures complied with the Guide for the Care and Use of Laboratory Animals (26) and the American Veterinary Medical Association guidelines on euthanasia (27) .
